Quantcast

Lawriter Introduces the First Social Network for Law Students

August 6, 2008

Lawriter, LLC a subsidiary of Collexis Holdings Inc. (OTCBB: CLXS) announced today the development of the first professional social network exclusively for law students. The site www.CasemakerX.com was showcased in Beta format at the American Association of Law Librarians Conference in Portland in July. A full launch is expected in early fall 2008 to coincide with the incoming class of new law students. Along with the social networking site, CasemakerX will provide free access to the Casemaker Suite of Applications for the U.S. law student community.

“CasemakerX is an exciting new legal information product that law students and faculty will find useful,” said Duncan Alford, associate dean and director of the law library at the University Of South Carolina School Of Law. “The social networking portion of CasemakerX is reminiscent of LinkedIn, but with the electronic content of primary federal and state law. The upcoming introduction of legal thesaurus searching will make the searching capabilities even more sophisticated and the success of the Collexis search engine and fingerprinting technology in medical research shows exciting promise for legal research.”

CasemakerX is a free service for law students supported by the Casemaker Bar Consortium and its 475,000 attorney members across the U.S. Law students, faculty and law librarians can sign up for the site and register from accredited Law Schools. Once a profile is created, users are networked by areas like corresponding law school, fields of interest, graduation year, etc. Users can also enjoy a host of social networking components including capabilities like blogging, instant messaging, photo sharing, job postings, video streaming via YouTube(TM), and iPhone plug-ins. Lawriter’s Casemaker suite of legal discovery products is available on the site and includes a library of over 12 Million documents in federal and state case law. The site also includes the recently released Casemaker Medical application, with full text search of over 15 Million biomedical abstracts.

“We are pleased to host this community for the next generation of attorneys,” said Steve Newsom, general manager for Lawriter. “Our mission is to help law students succeed – connecting with their peers, their teachers, and the external attorney community to advance their education and career goals.”

About the Casemaker Bar Consortium

The Casemaker Bar Consortium consists of twenty-eight State bars that are in strategic partnership with Lawriter, who provide the Bar’s members their Casemaker suite of discovery products for primary case law research, supplemental publications and continuing education materials. They are: Alabama, Alaska, Colorado, Connecticut, Georgia, Hawaii, Idaho, Indiana, Kansas, Kentucky, Maine, Massachusetts, Mississippi, Nebraska, New Hampshire, New Mexico, North Carolina, North Dakota, Ohio, Oregon, Rhode Island, South Carolina, Texas, Utah, Vermont, Washington, West Virginia, and Wyoming.

About Collexis Holdings, Inc.

Collexis Holdings, Inc., a leading developer of semantic search and knowledge discovery software, is headquartered in Columbia, South Carolina (USA) with major operations in Cincinnati, Ohio, Geldermalsen, the Netherlands and Cologne, Germany. Collexis now offers the world’s first pre-populated scientific social network for life science researchers, www.biomedexperts.com. Collexis’ proprietary technology builds conceptual profiles of text, called Fingerprints, from documents, Websites, emails and other digitized content and matches them with a comprehensive list of pre-defined “fingerprinted” concepts to make research results more relevant and efficient. This matching of concepts eliminates the ambiguity and lack of priority associated with word searches. The results are often described as “finding needles in many haystacks.” Through this novel approach, Collexis can build unique applications to search, index and aggregate information as well as prioritize, trend and predict data based on sources in multiple industries without the limitations of language or dialect. Collexis’ current clients in the public, private and academic sectors include the Mayo Clinic; Johns Hopkins University; Dana-Farber Cancer Institute, the University of California, San Francisco; the University of South Carolina; Erasmus University Library; Bristol-Myers Squibb; Lockheed Martin; the World Health Organization; Wellcome Trust; the National Institutes of Health; and the U.S. Department of Defense. Shares of Collexis common stock are traded under the symbol CLXS on the OTC Bulletin Board (OTC BB). For more information, visit www.collexis.com.

Forward-Looking Statements

Some of the statements made in this press release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s current expectations and include known and unknown risks, uncertainties and other factors, many of which the company is unable to predict or control, that may cause the company’s actual results or performance to differ materially from any future results or performance expressed or implied by such forward-looking statements. These statements involve risks and uncertainties, including risks and uncertainties associated with CasemakerX. These risks and uncertainties are in addition to other factors detailed from time to time in the company’s filings with the SEC, including the section entitled “Risk Factors” in its transition report on Form 10-KSB for the period ended June 30, 2007, as amended. The company cautions investors that any forward-looking statements made by the company are not necessarily indicative of future performance. The company is not responsible for updating the information contained in this press release beyond the published date, or for changes made to this document by wire services or Internet services.

Collexis and its activities are not sponsored by or controlled by Reed Elsevier Properties Inc. or its Licensee LexisNexis.




comments powered by Disqus